课题基金 / 基金详情

Evaluating the durability and cross-reactivity of SARS-CoV-2 immunity elicited by COVID-19 vaccines

Evaluating the durability and cross-reactivity of SARS-CoV-2 immunity elicited by COVID-19 vaccines
评估 COVID-19 疫苗引发的 SARS-CoV-2 免疫力的持久性和交叉反应性
批准号：
448964
负责人：
Brockman Mark A
金额：
$0.0万
依托单位：
Simon Fraser University (Burnaby, B.C.)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-04-01 至 2022-04-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=448964&lang=en
关键词：
B Cell Receptor (Bcr) Diversity Covid-19 Vaccines Elderly Adults Neutralizing Antibodies Single-Cell Rna Sequencing Viral Variants / Voc

项目摘要

项目成果

Brockman Mark A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has advanced rapidly from initial clinical observations in late 2019 to a global pandemic. Safe and effective vaccines offer our best opportunity to control spread of infec
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Harnessing cross-reactive T cell receptors to eliminate latent HIV reservoirs
Canada Research Chair Tier 2
2nd Afri-Can Forum of CHVI-funded HIV Prevention and Vaccine Teams
Barriers to engaging young people in HIV vaccine trials in a priority setting.
海外基金